MQ Ringversuche
|
Carba-R, NAT B25Carba-R |
|
Enterovirus, NAT B26Enterovirus |
|
Helicobacter Pylori Antigen B27Helicobacter fecal antigen |
|
VanA + VanB, NAT B29Vancomycin-resistant enterococcus (VRE) VanA and VanB |
|
Rotavirus + Adenovirus + Norovirus, antigen B30Rotavirus, Adenovirus, Norovirus antigene |
|
SARS-CoV-2, NAT B31SARS-CoV-2 |
|
SARS-CoV-2, antibodies B32SARS-CoV-2 IgM, IgG, IgA (also rapid tests) |
|
SARS-CoV-2, Antigene B33SARS-CoV-2 Antigene for rapid test |
|
FSME, antibodies B34Tick-borne encephalitis virus (FSME) IgG, IgM |
|
Measles + Parvovirus, antibodies B35Measles and Parvovirus IgG / IgM |
|
SARS-CoV-2 + Flu + RSV, NAT B36Influenza A, Influenza B, RSV, SARS CoV-2 |
|
C. Difficile (GDH, Toxin A/B) B37Clostridium difficile GDH, Toxin A, Toxin B for rapid ... |
|
Helicobacter urease test B38Gastroscopic urease test for Helicobacter pylori |
|
Mycobacteria B39Staining and evaluation of acid-fast rods |
|
Mycobacteria, culture TB (BSL3) B40Mycobacterium tuberculosis complex for level 3 biosafety ... |
|
Mycobacteria, culture 2 identification NTM (BSL2) B41Non-tuberculous mycobacteria for level 2 biosafety ... |
|
HIV + Hepatitis B + C B42HIV / Hepatitis B/C serology |
|
Hepatitis A Antibodies B43Hepatitis A Ig, IgM and IgG |
|
Hepatitis E Antibodies B44Hepatitis E IgG und IgM |
|
Coagulation oral anticoagulation G01Coagulation in patients on oral anticoagulation: INR, aPTT, ... |
|
INR CoaguCheck Pro II G02INR value |
|
Coagulation without anticoagulation G03Coagulation in patients without anticoagulation: Quick, ... |
|
Coagulation therapeutic heparinization G04Coagulation in patients under therapy with unfractionated ... |
|
Coagulation D-Dimer G06D-Dimer quantitative/qualitative evaluation |